68Ga-PSMA-11 Efficacy in Detecting BCR Prostate Cancer in Chinese Patients
חו"ל (דורש נסיעה)מגייס משתתפיםPHASE3
מצבים רפואיים
Biochemical Recurrence of Malignant Neoplasm of Prostate · Prostate Cancer · BCR Prostate Carcinoma
סיכום בשפה פשוטהבעזרת בינה מלאכותית
הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.
מיקומים
Peking University First Hospital, Beijing, China
Contact: Principal Investigator (Yan Fan)Xiangya Hospital Central South University, Changsha, China
Contact: Principal Investigator (Shuo Hu)Nanfang Hospital Southern Medical University, Guangzhou, China
Contact: Principal Investigator (Wanlong Tan)Fudan University Shanghai Cancer Center, Shanghai, China
Contact: Study coordinator (Principal Investigator) · info@telixpharma.com · 0086-021-64175590-88900Contact: Principal Investigator (Shaoli Song)West China Hospital of Sichuan University, Sichuan, China
Contact: Principal Investigator (Lin Li)Pengfei Shen (Sub-investigator)Wuhan Union Hospital, Wuhan, China
Contact: Principal Investigator (Xiaoli Lan, PhD)Zhongnan Hospital of Wuhan University, Wuhan, China
Contact: Principal Investigator (Yong He)Affiliated Hosptial of Jiangnan University, Wuxi, China
Contact: Principal Investigator (ChunJing Yu)